Anne Wojcicki

Anne Wojcicki is the co-founder of 23andMe and one of the most recognizable consumer-genomics operators in the world. Her angel pattern reflects that DNA: biotech, AI/ML in healthcare, and healthcare software, with a clear preference for data-rich, consumer-facing or genomics-adjacent businesses. AI focus is flagged. Seed and Series A, $250k+ checks. San Francisco-based. Best fit: founders working at the intersection of consumer health, genetics, longevity, and AI; data-platform or data-rich biotech plays; women’s health and reproductive genomics; anyone with a credible answer to consent, regulatory, and population-data scaling questions. Honest read: 23andMe’s recent struggles have not made her less of a magnet for founder pitches; she is hard to reach and selective. Entry path is LinkedIn (low hit rate cold), warm intros via the 23andMe research network, the Wojcicki family adjacent networks, or a syndicate lead she trusts. Not the right check for hardware-only medtech, B2B health IT, or pure services-heavy care delivery. If you get the meeting, expect questions about how you handle user data, consent, and longitudinal value extraction; vague answers will end the conversation quickly.